The 8 analysts offering 12-month price forecasts for Provention Bio Inc have a median target of 18.00, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +92.72% increase from the last price of 9.34.
The current consensus among 8 polled investment analysts is to Buy stock in Provention Bio Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.56
Reporting Date Feb 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.